Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Virion capsid protein VP1 is the major structural protein of the polyomavirus family and related viruses. It forms the main component of the viral capsid, which is responsible for protecting viral genetic material and mediating initial interactions with host cells during infection. It initiates infection by binding to sialic acids present on cell-surface glycans and is capable of self-organizing into virus-like particles. VP1 also binds directly to microtubules, stabilizing them and potentially affecting host cell cycle progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Virion Capsid Protein VP1 (VP1).